Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma by BCLC Stage”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Testing effectiveness (Phase 2)WithdrawnNCT05327738
What this trial is testing

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more
OHSU Knight Cancer Institute
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Large-scale testing (Phase 3)UnknownNCT03780049
What this trial is testing

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 304
Early research (Phase 1)Study completedNCT03515252
What this trial is testing

Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVHepatocellular Carcinoma by BCLC Stage+2 more
Ivy Life Sciences, Co., Ltd 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05883644
What this trial is testing

Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
AstraZeneca 111
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BRAVE Study: QL1706 + Bevacizumab + SBRT for BCLC-C HCC With PVTT or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 46
Large-scale testing (Phase 3)UnknownNCT03851913
What this trial is testing

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 344
Testing effectiveness (Phase 2)UnknownNCT02672488
What this trial is testing

Metformin Plus Sorafenib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 82
Testing effectiveness (Phase 2)Looking for participantsNCT06741020
What this trial is testing

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhejiang Cancer Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02940496
What this trial is testing

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatitis C Infection+8 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT05622071
What this trial is testing

Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
UNICANCER 50
Testing effectiveness (Phase 2)UnknownNCT04796025
What this trial is testing

TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 34
Testing effectiveness (Phase 2)UnknownNCT04992143
What this trial is testing

TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC

Who this might be right for
BCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang University 20
Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT00910572
What this trial is testing

Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 60
Not applicableUnknownNCT03652896
What this trial is testing

Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05507632
What this trial is testing

Donafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 48
Testing effectiveness (Phase 2)UnknownNCT04814030
What this trial is testing

Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 80
Testing effectiveness (Phase 2)WithdrawnNCT03775707
What this trial is testing

Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria

Who this might be right for
Hepatocellular Carcinoma
Shi Ming
Not applicableUnknownNCT02616926
What this trial is testing

Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 538
Load More Results